S&P 500
(0.06%) 5 472.40 points
Dow Jones
(0.10%) 39 150 points
Nasdaq
(0.34%) 17 778 points
Oil
(-0.21%) $80.66
Gas
(-3.66%) $2.66
Gold
(-0.79%) $2 312.50
Silver
(0.16%) $28.92
Platinum
(3.51%) $1 021.00
USD/EUR
(0.29%) $0.936
USD/NOK
(0.71%) $10.68
USD/GBP
(0.45%) $0.792
USD/RUB
(-0.28%) $87.25

实时更新: Fusion Pharmaceuticals [FUSN]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间5 Jun 2024 @ 04:00

0.00% $ 21.55

Live Chart Being Loaded With Signals

Commentary (5 Jun 2024 @ 04:00):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors...

Stats
今日成交量 0
平均成交量 2.11M
市值 1.83B
EPS $-0.400 ( Q1 | 2024-05-07 )
下一个收益日期 ( $0 ) 2024-08-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -15.39
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00500 (0.02%)
AADI -3.24%
ABCL 2.01%
ABCM 0.04%
ABEO -2.14%
ABIO -1.68%
ABOS 0.70%
ABSI 1.53%
ABUS -1.97%
ABVX -1.50%
ACAD -0.64%
ACER -17.95%
ACET -4.76%
ACGN 1.29%
ACHL -4.11%
ACHV 0.00%
ACIU -0.75%
ACLX 0.79%
ACRV -2.31%
ACST -2.90%
ACXP 1.38%
ADAG 4.64%
ADAP -4.19%
ADGI 0.87%
ADIL 1.75%
ADMA -2.13%
ADPT 0.00%
ADTX -2.08%
ADVM -3.62%
ADXN -1.60%
AEON -5.61%
AEZS -2.49%
AFMD -2.94%
AGEN -2.72%
AGIO -2.39%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -0.18%
AKRO -3.15%
AKTX 1.05%
AKUS 0.00%
ALBO 0.00%
ALDX -2.10%
ALEC 0.46%
ALGS -0.74%
ALKS 0.52%
ALLK -9.75%
ALLO -6.46%
ALLR -0.77%
ALNA 3.16%
ALNY 2.43%
ALPN 0.02%
ALPX 0.00%
ALRN -1.33%
ALT -9.45%
ALVR 2.98%
ALXN 0.00%
ALXO -13.10%
ALZN 5.27%
AMRN -0.45%
AMTI -3.13%
ANAB 1.09%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX 0.00%
ANPC -3.15%
APGE -0.91%
APGN 8.48%
APGNW 30.65%
APLM -2.32%
APLS 0.50%
APLT -3.04%
APM 0.36%
APOP 0.38%
APRE 0.60%
APTO 5.98%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -4.68%
ARDS -14.23%
ARDX 0.17%
ARGX -0.90%
ARNA 0.00%
ARPO -0.90%
ARQT -0.37%
ARTL -2.50%
ARTLW 0.00%
ARVN 4.97%
ARWR -1.06%
ASLN -5.07%
ASMB -5.81%
ASND -1.79%
ATAI -1.85%
ATHA 5.39%
ATHE 0.56%
ATHX -33.50%
ATNF 4.32%
ATOS 0.97%
ATRA -3.05%
ATXI -2.78%
ATXS -0.11%
AUPH -0.99%
AURA 2.79%
AUTL -1.58%
AVBP -3.32%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -3.47%
AVTX -1.25%
AVXL -3.95%
AXLA 0.00%
AXSM -1.11%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 3.44%
BCAB 4.89%
BCDA -2.23%
BCDAW -41.77%
BCEL 0.00%
BCLI 2.83%
BCRX 0.25%
BCTX 8.90%
BCTXW -16.32%
BCYC 0.75%
BDRX -4.64%
BDTX -1.81%
BEAM 1.07%
BFRA -2.91%
BGNE -2.40%
BIOR -5.21%
BIVI 3.41%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.78%
BLU 0.03%
BLUE -0.14%
BMEA -11.42%
BMRN 0.21%
BNOX 6.22%
BNTC -0.42%
BNTX -1.55%
BOLD -12.19%
BOLT -1.24%
BPMC -1.08%
BPTH 0.00%
BPTS -13.47%
BRNS 0.00%
BRTX -3.52%
BTAI 24.92%
BTTX 50.67%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 4.24%
CABA 1.59%
CADL -1.48%
CALA 0.00%
CALC -1.77%
CALT -1.59%
CAPR -1.73%
CARA -0.06%
CARM 13.05%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.22%
CCCC -5.84%
CCXI 0.00%
CDAK 0.00%
CDIO -2.25%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -7.72%
CDTTW -39.60%
CDTX -1.31%
CDXC 0.20%
CDXS 7.06%
CELC -4.37%
CELU -1.00%
CELUW 11.80%
CERC -1.68%
CERE -1.23%
CERO -3.45%
CEROW -21.56%
CFRX -27.95%
CGEM -2.98%
CGEN -3.05%
CGON -1.78%
CGTX -3.98%
CHMA -6.00%
CHRS 1.27%
CINC 0.00%
CING -0.63%
CINGW 34.95%
CKPT -3.35%
CLBS -16.75%
CLDX -1.33%
CLGN 0.34%
CLLS -4.15%
CLNN 1.92%
CLNNW 0.00%
CLRB 6.27%
CLSD 0.78%
CLSN -0.68%
CLVS 0.00%
CMMB -0.98%
CMND 0.00%
CMPI 0.00%
CMPX -1.42%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.47%
CNCE 0.00%
CNSP -36.88%
CNST 0.00%
CNTA -0.45%
CNTB 0.00%
CNTX -7.32%
COCP -2.00%
COEPW 32.45%
COGT -2.28%
CORT 2.75%
COYA -1.46%
CPRX -0.99%
CRBP -3.74%
CRBU -6.25%
CRDF -1.32%
CRGX -0.13%
CRIS -1.72%
CRNX -5.86%
CRSP 0.48%
CRTX 2.63%
CRVO -5.75%
CRVS 1.69%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -3.72%
CTNM -3.21%
CTXR 2.43%
CUE 6.57%
CVAC -4.94%
CVKD -2.85%
CWBR 2.80%
CYAD -12.96%
CYCC 9.09%
CYCCP 5.49%
CYCN -0.24%
CYT -2.27%
CYTK -2.46%
CYTO -1.83%
DARE 4.16%
DAWN -1.12%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 31.19%
DNLI -1.52%
DNTH -9.93%
DOMH 2.43%
DRMA -1.68%
DRMAW -1.25%
DRNA 0.00%
DRTS 3.45%
DRTSW 0.00%
DRUG 0.95%
DSGN -2.72%
DTIL 1.99%
DYAI 12.26%
EARS -1.77%
EDIT -2.61%
EDSA 3.19%
EFTR 5.89%
EFTRW -51.85%
EIGR -9.21%
ELAB -2.84%
ELDN 8.99%
ELEV -5.81%
ELOX -5.38%
ELTX -0.88%
ELVN -3.87%
ELYM 2.23%
ENGN -1.72%
ENGNW 0.00%
ENLV 2.90%
ENOB 1.79%
ENSC 3.23%
ENTA 0.08%
ENTO -2.42%
ENTX 1.60%
ENVB 1.58%
EPIX -2.36%
EPRX -1.15%
EPZM 0.00%
EQ 0.34%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.72%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -1.72%
ETON 2.13%
ETTX 0.00%
EVAX -2.14%
EVGN 4.76%
EVLO 0.00%
EWTX -0.63%
EXAI -1.32%
EXEL 0.04%
EYEG -0.69%
EYEN 1.42%
EYPT 0.61%
FATE -9.81%
FBIO 0.85%
FBIOP -0.37%
FBLG -15.00%
FBRX -0.02%
FDMT -3.50%
FENC -1.29%
FGEN -6.87%
FHTX 6.87%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.03%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.27%
FULC -3.68%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -5.36%
GANX -2.31%
GBIO -2.83%
GBT 0.01%
GDTC 0.50%
GERN -4.54%
GHRS -2.30%
GLMD -5.09%
GLPG -2.15%
GLSI 1.43%
GLTO -2.16%
GLUE -2.37%
GLYC -10.18%
GMAB -0.23%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -3.14%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -10.43%
GOVX 0.91%
GOVXW -49.04%
GPCR -8.54%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 1.31%
GRTX 5.14%
GTHX 0.23%
GUTS -5.08%
GXGXW 41.67%
GYRE -8.37%
HALO -1.09%
HARP 0.09%
HCWB -3.75%
HEPA -4.09%
HGEN -84.62%
HILS 5.66%
HLVX 0.00%
HOOK 2.03%
HOTH -3.51%
HOWL -2.14%
HRMY 1.73%
HRTX 3.77%
HSTO 0.00%
HUMA 0.71%
HUMAW -0.01%
IBRX -4.40%
ICCC 0.22%
ICPT 0.21%
ICU 17.39%
ICUCW 20.46%
ICVX -0.91%
IDRA -23.04%
IDYA -1.77%
IFRX -1.54%
IGMS -0.29%
IKNA 1.19%
IKT 0.70%
IMAB 2.03%
IMCR -2.96%
IMGN 0.02%
IMGO 0.00%
IMMP 4.75%
IMMX -7.76%
IMNM 1.04%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX -0.35%
IMTX -0.75%
IMTXW 6.00%
IMUX 1.85%
IMV 0.00%
IMVT -5.02%
INAB -0.56%
INBX 1.13%
INCY -1.28%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM 3.14%
INMB 1.68%
INO -1.37%
INSM -1.26%
INTS -2.75%
INVA 0.56%
INZY 0.69%
IOBT -11.02%
IONS 0.70%
IOVA -2.96%
IPA -0.49%
IPHA 5.58%
IPSC -2.34%
IRON -1.64%
ISEE 0.38%
ITOS -1.71%
ITRM 1.67%
IVA 6.96%
IVVD -2.48%
JAGX 0.79%
JANX -3.90%
JAZZ -0.45%
JNCE 0.00%
JSPR -5.85%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -5.02%
KDNY 0.22%
KMPH -0.34%
KNSA -2.06%
KNTE -0.38%
KOD -6.13%
KPRX 0.96%
KPTI -5.05%
KRBP -10.00%
KRON 0.58%
KROS -1.10%
KRRO -8.11%
KRTX 0.03%
KRYS -0.40%
KTRA 8.11%
KTTA -6.79%
KTTAW 0.92%
KURA -0.29%
KYMR -3.01%
KYTX -3.89%
KZIA 2.65%
KZR -0.60%
LABP 0.57%
LBPH -1.18%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.82%
LENZ -5.29%
LEXX 0.78%
LEXXW -14.63%
LGND -0.50%
LGNDV 0.00%
LGVN -7.47%
LIAN -8.28%
LIFE 2.70%
LIPO -3.87%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.04%
LPCN -1.86%
LPTX -1.92%
LQDA -0.16%
LRMR -1.56%
LSTA -4.06%
LTRN 1.37%
LUMO -1.32%
LVTX -1.03%
LXEO -2.79%
LXRX -2.05%
LYEL -36.03%
LYRA 1.16%
MACK 0.10%
MBIO -9.96%
MBRX -1.72%
MCRB 3.17%
MDGL -0.97%
MDNA -13.16%
MDWD -0.34%
MDXG -2.80%
MEIP 1.40%
MESO -1.41%
MGNX -2.80%
MGTA -7.74%
MGTX -3.68%
MGX -2.68%
MIRM -1.27%
MIRO 0.59%
MIST 1.15%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX 0.71%
MLYS -7.56%
MNKD 0.38%
MNMD -0.07%
MNOV 2.11%
MNPR -8.52%
MOLN 1.79%
MOR 1.20%
MORF -3.40%
MREO -3.29%
MRKR 2.57%
MRNA -5.96%
MRNS -4.04%
MRSN -2.38%
MRTX -0.17%
MRUS 0.37%
MRVI -1.53%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.08%
MYMD 5.46%
NAMS 2.75%
NAMSW -0.21%
NAUT 1.55%
NBRV 0.71%
NBSE -1.56%
NBTX 12.09%
NCNA 0.73%
NERV -0.63%
NEXI 4.04%
NGM -1.28%
NGNE -1.87%
NKGN 9.46%
NKGNW 8.00%
NKTR -4.21%
NKTX -5.38%
NLSP 5.35%
NLSPW 26.67%
NMRA -2.86%
NMTR -42.97%
NOVN -24.84%
NRBO 10.32%
NRIX -2.12%
NRSN -5.12%
NRSNW 0.00%
NRXP -4.58%
NRXPW 18.33%
NRXS 4.82%
NTBL 3.42%
NTEC -12.45%
NTHI 0.00%
NTLA -7.19%
NTRBW -31.07%
NUVL -1.69%
NVAX -2.50%
NVCT 3.55%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 1.58%
OABIW -10.06%
OBIO -3.07%
OBSV 0.00%
OCEA 0.00%
OCGN 2.97%
OCS -1.00%
OCUL -0.15%
OCUP 1.84%
ODT -4.27%
OKYO 1.51%
OLMA -5.29%
OMER -1.03%
OMGA 5.41%
ONCO 4.54%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY 1.49%
ONTX -0.47%
ONVO 0.47%
OPNT 0.00%
OPT 3.09%
ORGS 0.96%
ORIC -3.49%
ORMP 17.41%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.22%
OVID 0.61%
OYST 0.00%
PALI 1.30%
PASG -1.30%
PBLA -7.50%
PBM -4.84%
PBYI 1.52%
PCSA 0.00%
PCVX -0.30%
PDSB -4.59%
PEPG 0.09%
PGEN -2.99%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -0.83%
PHIOW 36.47%
PHVS -7.32%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.47%
PLUR 7.39%
PMN 0.72%
PMVP -0.30%
PNT 0.16%
PPBT -5.61%
PRAX 3.20%
PRDS 0.93%
PRLD -2.37%
PROG -3.47%
PROK 0.00%
PRQR -0.66%
PRTA -2.70%
PRTC 0.49%
PRTG 7.02%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -10.37%
PSTX -1.94%
PTCT -0.51%
PTE -0.82%
PTGX -0.91%
PTIXW -48.41%
PULM 2.60%
PXMD 4.76%
PYPD 0.07%
PYXS 1.63%
QLGN -3.00%
QNCX 5.70%
QNRX -1.34%
QSI -11.54%
QSIAW -3.13%
QTTB -3.42%
QURE -0.79%
RAIN -1.63%
RANI 6.42%
RAPT -1.26%
RARE 1.27%
RCKT -8.81%
REGN 0.21%
RENB -3.11%
REPL -2.27%
RETA 0.02%
REUN -0.89%
REVB -2.79%
REVBU 3.46%
REVBW 4.38%
RGLS -6.54%
RGNX -5.56%
RIGL -3.28%
RLAY -3.56%
RLMD 0.35%
RLYB -1.01%
RNA 0.62%
RNAC -2.94%
RNAZ -1.90%
RNXT 0.89%
ROIV -2.08%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.33%
RPTX 0.15%
RUBY 2.70%
RVLP -32.05%
RVMD -0.98%
RVMDW -30.00%
RVNC 0.21%
RVPH -2.38%
RVPHW 1.62%
RXDX 0.09%
RXRX -4.96%
RYTM -5.05%
RYZB 0.02%
RZLT 3.93%
SABS -1.37%
SABSW -11.81%
SAGE 1.19%
SANA -3.69%
SAVA -0.16%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -0.06%
SCPH 5.32%
SCPS 0.00%
SEEL -4.12%
SEER 0.59%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.30%
SGMT -2.42%
SGTX -2.56%
SIOX 22.63%
SLDB -9.57%
SLGL 4.12%
SLN -4.57%
SLNO -4.39%
SLRX 5.26%
SLS -1.71%
SMMT -1.62%
SNDX 1.28%
SNGX -4.91%
SNPX -4.44%
SONN -0.01%
SPPI -0.49%
SPRB 0.63%
SPRC -2.75%
SPRO 0.05%
SRNE -34.00%
SRPT -1.11%
SRRA 0.00%
SRRK -1.98%
SRZN -2.45%
STAB 0.00%
STOK -5.66%
STRO -4.01%
STSA 0.00%
STTK -1.67%
SURF -0.93%
SVRA -8.02%
SWTX -0.44%
SYBX -1.29%
SYRS -1.55%
TALS -0.73%
TARA -7.14%
TARS 0.45%
TBPH 0.60%
TCBP 2.48%
TCDA 0.00%
TCON 2.46%
TCRR 0.00%
TCRT 0.08%
TCRX -1.05%
TECH -0.21%
TENX 1.91%
TERN -8.21%
TFFP -5.33%
TGTX -4.40%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -4.60%
TNGX -3.13%
TNXP -6.00%
TNYA -5.08%
TPST 4.88%
TRDA -4.06%
TRVI 2.30%
TRVN 6.50%
TSHA -22.68%
TSVT -2.93%
TTNP -7.66%
TVTX 1.26%
TYRA -8.54%
UBX -2.48%
UNCY -4.00%
URGN -1.15%
UTHR 0.57%
VACC 11.36%
VALN -4.07%
VAXX 116.88%
VBIV 0.31%
VBLT -8.77%
VCEL 0.74%
VCNX 10.35%
VCYT -1.67%
VERA -3.92%
VERU 0.98%
VERV -3.06%
VIGL 4.84%
VINC 2.28%
VIR 1.08%
VIRI -1.85%
VIRX 3.26%
VKTX -1.40%
VLON -13.04%
VNDA -3.50%
VOR -2.02%
VRCA -0.28%
VRDN -4.55%
VRNA -0.80%
VRPX 0.38%
VRTX 0.39%
VSTM -1.19%
VTGN -0.91%
VTVT -2.97%
VTYX -0.84%
VXRT -4.09%
VYGR -0.38%
VYNE -4.62%
VYNT 7.78%
WINT 2.18%
WVE -6.39%
XBIO 1.03%
XBIT -2.92%
XCUR 3.55%
XENE -1.38%
XERS 2.62%
XFOR 4.69%
XLO 2.19%
XLRN 0.00%
XNCR 0.52%
XOMA -2.53%
XOMAO -0.16%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.73%
ZNTL -2.38%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-04 Bitetti Teresa Marie Sell 34 000 Stock Option (Right to Buy)
2024-06-04 Gannon Steven Sell 56 400 Common Stock
2024-06-04 Gannon Steven Sell 141 011 Stock Option (Right to Buy)
2024-06-04 Gannon Steven Sell 30 000 Stock Option (Right to Buy)
2024-06-04 Gannon Steven Sell 17 000 Stock Option (Right to Buy)
INSIDER POWER
-67.50
Last 97 transactions
Buy: 3 027 300 | Sell: 8 744 008
相关性 (AI algo v.1.1b): Undervalued: 0.09% $21.59 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量 相关性

長: 0.77 (moderate)
短: 0.84 (strong)
Signal:(74.81) Same movement expected

Fusion Pharmaceuticals 相关性

10 最正相关
RGLS0.952
DXPE0.944
GHRS0.93
CTHR0.924
CDXC0.924
IMPPP0.921
GIFI0.921
SWBI0.921
QFIN0.92
LFMDP0.918
10 最负相关
RMGC-0.948
IMRX-0.947
ACAD-0.945
PRTS-0.941
MTEM-0.94
CMTL-0.94
CASI-0.934
RGF-0.934
AZ-0.932
BTTX-0.93

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Fusion Pharmaceuticals 相关性 - 货币/商品

The country flag -0.01
( neutral )
The country flag 0.39
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.57
( weak )

Fusion Pharmaceuticals 财务报表

Annual 2023
营收: $2.07M
毛利润: $723 000 (34.96 %)
EPS: $-1.450
FY 2023
营收: $2.07M
毛利润: $723 000 (34.96 %)
EPS: $-1.450
FY 2022
营收: $1.46M
毛利润: $-57.43M (-3 931.14 %)
EPS: $-2.00
FY 2021
营收: $1.44M
毛利润: $0.00 (0.00 %)
EPS: $-1.884

Financial Reports:

No articles found.

Fusion Pharmaceuticals Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Fusion Pharmaceuticals

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。

Total Execution Time: 4.5771050453186 seconds
Number of API calls: 3
Number of DB calls: 9